Literature DB >> 21443663

Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community.

Nirmala Pandeya1, David C Whiteman.   

Abstract

BACKGROUND AND AIM: To estimate the sero-prevalence of Helicobacter Pylori infection in the Australian adult population and identify determinants.
METHODS: We analyzed serum samples and questionnaire data from 1355 community controls who participated in a nationwide case-control study of esophageal cancer in Australia between 2002 and 2005. We estimated the prevalence ratio and 95% confidence interval using log binomial regression models.
RESULTS: The age and sex standardized sero-prevalence of H. pylori was 15.5%. The prevalence of infection varied significantly with age, ranging from 5% (< 40 years) to 32% (≥ 70 years). H. pylori infection was significantly higher among those born overseas (prevalence ratio [PR] 1.63; 95% confidence interval [CI] 1.34-1.98) compared with those born in Australia or New Zealand. H. pylori sero-prevalence was 23% higher among participants living in the lowest quartile of socio-economic areas (PR 0.77; 95%CI 0.59-0.99 for Q4 compared with Q1). H pylori serostatus was significantly inversely associated with university education (PR 0.56; 95%CI 0.38-0.83), frequent reflux symptoms (PR 0.62; 95%CI 0.42-0.91), use of proton pump inhibitor (PR 0.69; 95%CI 0.48-0.98) and use of medications for gut spasms (PR 0.48; 95%CI 0.25-0.93). H. pylori serostatus was not associated with body mass index, smoking, alcohol or physical activity.
CONCLUSIONS: The prevalence of H. pylori infection in Australian adults is lower than other developed countries. H. pylori infection is most common among those living in the areas of socio-economic disadvantage or who were born overseas.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443663     DOI: 10.1111/j.1440-1746.2011.06726.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

Review 1.  Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics.

Authors:  Abu Iftiaf Md Salah Ud-Din; Anna Roujeinikova
Journal:  Cell Mol Life Sci       Date:  2017-10-27       Impact factor: 9.261

2.  Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010.

Authors:  Thomas Wex; Marino Venerito; Juliane Kreutzer; Tobias Götze; Arne Kandulski; Peter Malfertheiner
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

Review 3.  Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage.

Authors:  Bárbara Peleteiro; Ana Bastos; Ana Ferro; Nuno Lunet
Journal:  Dig Dis Sci       Date:  2014-02-22       Impact factor: 3.199

Review 4.  Population screening and treatment of Helicobacter pylori infection.

Authors:  Anthony O'Connor; Colm A O'Morain; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 5.  Epidemiology of Helicobacter pylori infection and public health implications.

Authors:  Khean-Lee Goh; Wah-Kheong Chan; Seiji Shiota; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2011-09       Impact factor: 5.753

6.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

Review 7.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

8.  Stomach bugs and diabetes: an astounding observation or just confounding?

Authors:  Christopher K Rayner; Nicholas J Talley; Michael Horowitz
Journal:  Diabetes Care       Date:  2012-03       Impact factor: 19.112

9.  Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview.

Authors:  David C Whiteman; Penelope M Webb; Adele C Green; Rachel E Neale; Lin Fritschi; Christopher J Bain; D Max Parkin; Louise F Wilson; Catherine M Olsen; Christina M Nagle; Nirmala Pandeya; Susan J Jordan; Annika Antonsson; Bradley J Kendall; Maria Celia B Hughes; Torukiri I Ibiebele; Kyoko Miura; Susan Peters; Renee N Carey
Journal:  Aust N Z J Public Health       Date:  2015-10       Impact factor: 2.939

10.  Cancers in Australia in 2010 attributable to infectious agents.

Authors:  Annika Antonsson; Louise F Wilson; Bradley J Kendall; Christopher J Bain; David C Whiteman; Rachel E Neale
Journal:  Aust N Z J Public Health       Date:  2015-10       Impact factor: 2.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.